This is an exploratory, multicenter, randomized, blinded, placebo-controlled study of Mucinex
in patients with colds. Patients will receive 7 days of treatment with either Mucinex or
placebo. The study will assess the effects of Mucinex on sputum and cold symptoms.
Phase:
Phase 2
Details
Lead Sponsor:
Reckitt Benckiser Inc. Reckitt Benckiser LLC
Treatments:
Chlorpheniramine, phenylpropanolamine drug combination Guaifenesin Phenylpropanolamine